Medicaid
-
CMS issues final 2027 Medicare Advantage and Part D Payment Rates
Payor and provider groups are saying the rate increases may not be enough to stave off cuts to coverage.
-
Sanders and Khanna introduce Make Billionaires Pay Their Fair Share Act
“We can no longer tolerate a corrupt tax code that enables billionaires to pay a lower tax rate,” said Sanders.
-
HHS agency signals drug rebate program redux with request for information
The RFI is the Trump administration’s next move to get its drug pricing rebate program back on track after hospital groups blocked it last year.
-
FCA Healthcare roundup: Three cases of Medicare and Medicaid fraud in IL, MN, NY
Our in-brief, biweekly roundup of notable US Department of Justice False Claims Act cases related to healthcare fraud.
-
AMA survey reveals state health policy priorities and challenges
The survey of the 64 physician organizations spotlights their leading healthcare priorities, defining the state-level legislative – and risk – landscape in 2026.
-
DOJ secures record-breaking $6.8 billion in False Claims Act settlements, judgments for FY 2025
The healthcare fraud category took the lion’s share with a staggering $5.7 billion in recovered funds from FCA matters.
-
CMS presents shake-up for Medicare Advantage star ratings
The agency suggested dropping 12 quality measures of health plan performance and refocusing on aspects like patient experience.
-
CMS quietly rolls out new round of Medicare-negotiated drug prices
The second-cycle negotiated-price drugs include medicines to treat cancer, asthma, and metabolic conditions.